Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 3,121 | 2,577 | 0 |
| Operating Income | -3,121 | -2,577 | N/A |
| Interest Expense | -3 | 754 | 0 |
| Other Income | 288 | 2,710 | 0 |
| Pre-tax Income | -2,830 | -621 | 0 |
| Net Income Continuous | -2,830 | -621 | N/A |
| Net Income | $-2,830 | $-621 | $N/A |
| EPS Basic Total Ops | -103.19 | -3.09 | N/A |
| EPS Basic Continuous Ops | -5.61 | -1.30 | N/A |
| EPS Diluted Total Ops | -103.19 | -3.09 | N/A |
| EPS Diluted Continuous Ops | -5.61 | -1.30 | N/A |
| EBITDA(a) | $-3,121 | $-1,825 | $N/A |